QIAGEN bioinformatics and NGS solutions enable genomic breakthroughs
Hilden, Germany, and Germantown, Maryland, October 12, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its Sample to Insight solutions, from next-generation sequencing (NGS) technologies to bioinformatics solutions for research and clinical testing, figure prominently in independent studies presented this week at the American Society of Human Genetics (ASHG) annual... Read more